Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation

Jo Thompson-Coon, Martin Hoyle, Colin Green, Zulian Liu, Karen Welch, Tiffany Moxham, Ken Stein

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherUniversity of Exeter
Commissioning bodyThe National Institute for Health and Care Excellence (NICE)
Number of pages307
Publication statusPublished - 2008
Externally publishedYes

Cite this